Literature DB >> 8478876

The validity of pooled outcome measures (indices) in rheumatoid arthritis clinical trials.

M Boers1, P Tugwell.   

Abstract

No consensus exists on the appropriate (set of) endpoints to be reported in rheumatoid arthritis clinical trials. The traditional endpoints are not comprehensive, show overlap, and are insensitive to change. A single, pooled outcome measure or index may be an alternative. However, such an index must be valid and acceptable. An overview of the existing indices suggests several options are available. To date, practical experience with these indices in trials is limited.

Entities:  

Mesh：

Year:  1993        PMID： 8478876

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  5 in total

1.  The ICIDH-2 as a framework for the assessment of functioning and disability in rheumatoid arthritis.

Authors:  J Fransen; D Uebelhart; G Stucki; T Langenegger; M Seitz; B A Michel
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

2.  A randomised controlled trial of occupational therapy for people with early rheumatoid arthritis.

Authors:  A Hammond; A Young; R Kidao
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

3.  Data-driven desirability function to measure patients' disease progression in a longitudinal study.

Authors:  Hsiu-Wen Chen; Weng Kee Wong; Hongquan Xu
Journal:  J Appl Stat       Date:  2015-10-09       Impact factor: 1.404

4.  Characterization of missing data patterns and mechanisms in longitudinal composite outcome trial in rheumatoid arthritis.

Authors:  Fowzia Ibrahim; Brian D M Tom; David L Scott; Andrew Toby Prevost
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-09-17       Impact factor: 3.625

Review 5.  Outcome measures in inflammatory rheumatic diseases.

Authors:  Jaap Fransen; Piet L C M van Riel
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.